Regenerative medicine firm Orthocell has obtained CE-Mark for its CelGro medical device, allowing marketing within the European Union (EU) countries.

Developed using the firm’s SMRT tissue engineering process, the collagen scaffold device is indicated for use in various dental bone and soft tissue regeneration procedures.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

CelGro is designed to target a range of orthopaedic, reconstructive and surgical applications with global commercial potential in current addressable bone, tendon, nerve and cartilage markets.

Orthocell managing director Paul Anderson said: “European regulatory approval for CelGro marks a major milestone for Orthocell as it enables commercial roll-out in the lucrative dental bone and soft tissue regeneration market, where there is a significant and growing demand and market opportunity.

“The CE-Mark also validates the potential of the entire technology platform by endorsing CelGro’s clinical performance and quality manufacturing.”

“The approval is expected to support the device’s dental regulatory applications in other key markets, including the US, Japan and Australia.”

The approval is expected to support the device’s dental regulatory applications in other key markets, including the US, Japan and Australia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Orthocell is currently working on forming strategic commercial partnerships for product distribution in Europe and other select regions.

In addition to dental and tissue regeneration, the CelGro technology platform could be used in different neurological, orthopaedic and surgical applications such as peripheral nerve repair, tendon, ligaments, cartilage and bone, general surgery, and urogynaecological procedures.

During clinical studies, the device is reported to have demonstrated improved tissue-ingrowth and repair when used for rotator cuff tendon repair in the shoulder, bone regeneration in the jaw and re-joining of severed or damaged peripheral nerves.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact